Synthesis, characterization, and evaluation of biological activities of new 4′‐substituted ruthenium (II) terpyridine complexes: Prospective anti‐inflammatory properties
- 11 September 2020
- journal article
- research article
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 35 (1)
Abstract
The synthesis and characterization of Ru (II) terpyridine complexes derived from 4′ functionalized 2,2′:6′,2″‐terpyridine (tpy) ligands are reported. The heteroleptic complexes comprise the synthesized ligands 4′‐(2‐thienyl)‐ 2,2′:6′,2″‐terpyridine) or (4′‐(3,4‐dimethoxyphenyl)‐2,2′:6′,2″‐terpyridine and (dimethyl 5‐(pyrimidin‐5‐yl)isophthalate). The new complexes [Ru(4′‐(2‐thienyl)‐2,2′:6′,2″‐terpyridine)(5‐(pyrimidin‐5‐yl)‐isophthalic acid)Cl2] (9), [Ru(4′‐(3,4‐dimethoxyphenyl)‐2,2′:6′,2″‐terpyridine)(5‐(pyrimidin‐5‐yl)‐isophthalic acid)Cl2] (10), and [Ru(4′‐(2‐thienyl)‐2,2′:6′,2″‐terpyridine)(5‐(pyrimidin‐5‐yl)‐isophthalic acid)(NCS)2] (11) were characterized by 1H‐ and 13C‐NMR spectroscopy, C, H, N, and S elemental analysis, UPLC‐ESI‐MS, TGA, FT‐IR, and UV‐Vis spectroscopy. The biological activities of the synthesized ligands and their Ru (II) complexes as anti‐inflammatory, antimicrobial, and anticancer agents were evaluated. Furthermore, the toxicity of the synthesized compounds was studied and compared with the standard drugs, namely, diclofenac potassium and ibuprofen, using hemolysis assay. The results indicated that the ligands and the complex 9 possess superior anti‐inflammatory activities inhibiting albumin denaturation (89.88–100%) compared with the standard drugs (51.5–88.37%) at a concentration of 500 μg g−1. These activities were related to the presence of the chelating N‐atoms in the ligands and the exchangeable chloro‐ groups in the complex. Moreover, the chloro‐ and thiophene groups in complex 9 produce a higher anticancer activity compared with its isothiocyanate derivative in the complex 11 and the 3,4‐dimethoxyphenyl moiety in complex 10. Considering the toxicity results, the synthesized ligands are nontoxic or far less toxic compared with the standard drugs and the metal complexes. Therefore, these newly synthesized compounds are promising anti‐inflammatory agents in addition to their moderate unique broad antimicrobial activity.Keywords
This publication has 60 references indexed in Scilit:
- Ru(ii) complexes with N-heterocyclic carbene ligands or terpyridine analogues: synthesis, characterization, and electrochemical and proton-dependent spectrometric propertiesDalton Transactions, 2012
- Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell modelToxicology Letters, 2011
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugsDalton Transactions, 2011
- Inhibition of Herpesvirus Replication by 5-Substituted 4′-Thiopyrimidine NucleosidesAntimicrobial Agents and Chemotherapy, 2009
- Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and InvasionMetal-Based Drugs, 2009
- New Family of Ruthenium‐Dye‐ Sensitized Nanocrystalline TiO2 Solar Cells with a High Solar‐Energy‐Conversion EfficiencyAdvanced Functional Materials, 2007
- Mechanism of quenching by oxygen of the excited states of ruthenium( ii ) complexes in aqueous media. Solvent isotope effect and photosensitized generation of singlet oxygen, O 2 ( 1 Δ g ), by [Ru(diimine)(CN) 4 ] 2− complex ionsDalton Transactions, 2007
- Inflammation and cancerNature, 2002
- Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-Terpyridine derivativesBioorganic & Medicinal Chemistry Letters, 2001
- The mechanism of divalent metal ion chelator induced activation of the 7S nerve growth factor esteropeptidase. Activation by 2,2',2"-terpyridine and by 8-hydroxyquinoline-5-sulfonic acidBiochemistry, 1976